The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond
Open accessAbstract
IMPORTANCE: E-cadherin (CDH1) is a cancer predisposition gene mutated in families meeting clinically defined hereditary diffuse gastric cancer (HDGC). Reliable estimates of cancer risk and spectrum in germline mutation carriers are essential for management. For families without CDH1 mutations, genetic-based risk stratification has not been possible, resulting in limited clinical options. OBJECTIVES: To derive accurate estimates of gastric and breast cancer risks in CDH1 mutation carriers and determine if germline mutations in other genes are associated with HDGC. DESIGN, SETTING, AND PARTICIPANTS: Testing for CDH1 germline mutations was performed on 183 index cases meeting clinical criteria for HDGC. Penetrance was derived from 75 mutation-positive families from within this and other cohorts, comprising 3858 probands (353 with gastric cancer and 89 with breast cancer). Germline DNA from 144 HDGC probands lacking CDH1 mutations was screened using multiplexed targeted sequencing for 55 cancer-associated genes. MAIN OUTCOMES AND MEASURES: Accurate estimates of gastric and breast cancer risks in CDH1 mutation carriers and the relative contribution of other cancer predisposition genes in familial gastric cancers. RESULTS: Thirty-one distinct pathogenic CDH1 mutations (14 novel) were identified in 34 of 183 index cases (19%). By the age of 80 years, the cumulative incidence of gastric cancer was 70% (95% CI, 59%-80%) for males and 56% (95% CI, 44%-69%) for females, and the risk of breast cancer for females was 42% (95% CI, 23%-68%). In CDH1 mutation-negative index cases, candidate mutations were identified in 16 of 144 probands (11%), including mutations within genes of high and moderate penetrance: CTNNA1, BRCA2, STK11, SDHB, PRSS1, ATM, MSR1, and PALB2. CONCLUSIONS AND RELEVANCE: This is the largest reported series of CDH1 mutation carriers, providing more precise estimates of age-associated risks of gastric and breast cancer that will improve counseling of unaffected carriers. In HDGC families lacking CDH1 mutations, testing of CTNNA1 and other tumor suppressor genes should be considered. Clinically defined HDGC families can harbor mutations in genes (ie, BRCA2) with different clinical ramifications from CDH1. Therefore, we propose that HDGC syndrome may be best defined by mutations in CDH1 and closely related genes, rather than through clinical criteria that capture families with heterogeneous susceptibility profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
E-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
Self-citationMorphogenetic roles of classic cadherins
Takeichi, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80102-2 · Cited by 1,450
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Breast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400382 · Cited by 851
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 1×
“P13 (Italian) 4 LBC (39) GC (53), GC (44), BC and uterine (34), BC (NA) Brain (NA) DD SDHB (1) c.”
Correa, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1881 · Cited by 737
Pharoah, P. D. P., Guilford, P., & Caldas, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.29611 · Cited by 638
Self-citationPrograms for pedigree analysis: Mendel, Fisher, and dGene
Lange, K., Weeks, D., Boehnke, M., MacCluer, J. W., & MacCluer, J. W. (1988) · Genetic Epidemiology · doi:10.1002/gepi.1370050611 · Cited by 616
Mutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Fitzgerald, R. C., Hardwick, R., Huntsman, D., Carneiro, F., Guilford, P., Blair, V., Chung, D. C., Norton, J., Ragunath, K., Van Krieken, J. H., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.074237 · Cited by 542
Self-citationFamilial gastric cancer: overview and guidelines for management.
Caldas, C. H., Carneiro, F., Lynch, H. T., et al. (1999) · PubMed · Cited by 508
Self-citationA recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A., Pylkäs, K., Karppinen, S.-M., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J.-G., et al. (2000) · Nature Genetics · doi:10.1038/79120 · Cited by 447
Self-citationFounder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
Kaurah, P., MacMillan, A., Boyd, N., Senz, J., De Luca, A., Chun, N., Suriano, G., Zaor, S., Van Manen, L., Gilpin, C., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2360 · Cited by 447
Self-citationEarly Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations
Huntsman, D. D., Carneiro, F., Lewis, F. R., MacLeod, P., Hayashi, A., Monaghan, K. G., Maung, R., Seruca, R., Jackson, C. E., & Caldas, C. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442504 · Cited by 416
Self-citationXu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J., Sterling, D., Lange, E. M., Hawkins, G. A., Turner, A., et al. (2002) · Nature Genetics · doi:10.1038/ng994 · Cited by 392
Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y. S. N., Jeyes, J., Schinas, J., Bacani, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018275 · Cited by 361
Self-citationRichards, F. M., McKee, S. A., Rajpar, M. H., Cole, T. R. P., Evans, D. G. R., Jankowski, J. A., McKeown, C., Sanders, D. S. A., & Maher, E. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.607 · Cited by 328
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
Moran, A., O’Hara, C., Khan, S., Shack, L., Woodward, E., Maher, E. R., Lalloo, F., & Evans, D. G. R. (2012) · Familial Cancer · doi:10.1007/s10689-011-9506-2 · Cited by 307
Chan, A. O.-O., Lam, S.-K., Wong, B. C.-Y., Wong, W.-M., Yuen, M.-F., Yeung, Y.-H., Hui, W.-M., Rashid, A., & Kwong, Y.-L. (2003) · Gut · doi:10.1136/gut.52.4.502 · Cited by 300
Keller, G., Vogelsang, H., Becker, I., Hutter, J., Ott, K., Candidus, S., Grundei, T., Becker, K.-F., Mueller, J., Siewert, J. R., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65129-2 · Cited by 287
Self-citationThe structural and functional analysis of cadherin calcium-dependent cell adhesion molecules
Grunwald, G. B. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90028-o · Cited by 287
Founder mutations in BRCA1 and BRCA2 genes
Ferla, R., Calò, V., Cascio, S., Rinaldi, G., Badalamenti, G., Carreca, I., Surmacz, E., Colucci, G., Bazan, V., & Russo, A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm234 · Cited by 286
Guilford, P. J., Hopkins, J. B. W., Grady, W. M., Markowitz, S. D., Willis, J., Lynch, H., Rajput, A., Wiesner, G. L., Lindor, N. M., Burgart, L. J., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:3<249::aid-humu8>3.0.co;2-9 · Cited by 283
Self-citationRare variants in the ATMgene and risk of breast cancer
Goldgar, D. E., Healey, S., Dowty, J. G., Da Silva, L., Chen, X., Spurdle, A. B., Terry, M. B., Daly, M. J., Buys, S. M., Southey, M. C., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2919 · Cited by 226
Janavičius, R. (2010) · EPMA Journal · doi:10.1007/s13167-010-0037-y · Cited by 223
Ni, Y., Zbuk, K. M., Sadler, T., Patocs, A., Lobo, G., Edelman, E., Platzer, P., Orloff, M. S., Waite, K. A., & Eng, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.011 · Cited by 222
An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer
Majewski, I. J., Kluijt, I., Cats, A., Scerri, T. S., de Jong, D., Kluin, R. J., Hansford, S., Hogervorst, F. B., Bosma, A. J., Hofland, I., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4152 · Cited by 222
Self-citationGermline CDH1 deletions in hereditary diffuse gastric cancer families
Oliveira, C., Senz, J., Kaurah, P., Pinheiro, H., Sanges, R., Haegert, A., Corso, G., Schouten, J., Fitzgerald, R., Vogelsang, H., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp046 · Cited by 217
Self-citationSarrió, D., Moreno‐Bueno, G., Hardisson, D., Sánchez‐Estévez, C., Guo, M., Herman, J. G., Gamallo, C., Esteller, M., & Palacios, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11197 · Cited by 209
Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., Mullikin, J. C., & Biesecker, L. G. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.021 · Cited by 206
Hereditary pancreatitis caused by triplication of the trypsinogen locus
Le Maréchal, C., Masson, E., Chen, J.-M., Morel, F., Ruszniewski, P., Levy, P., & Férec, C. (2006) · Nature Genetics · doi:10.1038/ng1904 · Cited by 202
Germline E-cadherin mutations in familial lobular breast cancer
Masciari, S., Larsson, N., Senz, J., Boyd, N., Kaurah, P., Kandel, M. J., Harris, L. N., Pinheiro, H. C., Troussard, A., Miron, P., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051268 · Cited by 190
Self-citationBenusiglio, P. R., Malka, D., Rouleau, É., Pauw, A. D., Buecher, B., Noguès, C., Fourme, E., Colas, C., Coulet, F., Warcoin, M., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101472 · Cited by 166
Genetics, Pathology, and Clinics of Familial Gastric Cancer
Oliveira, C., Seruca, R., & Carneiro, F. (2006) · International Journal of Surgical Pathology · doi:10.1177/106689690601400105 · Cited by 162
Self-citationOliveira, C., Bordin, M. C., Grehan, N., Huntsman, D., Suriano, G., Machado, J. C., Kiviluoto, T., Aaltonen, L., Jackson, C. E., Seruca, R., et al. (2002) · Human Mutation · doi:10.1002/humu.10068 · Cited by 159
Self-citationForcet, C., Etienne‐Manneville, S., Gaude, H., Fournier, L., Debilly, S., Salmi, M., Baas, A. F., Olschwang, S., Clevers, H. C., & Billaud, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi139 · Cited by 157
Orloff, M. S., Peterson, C., He, X., Ganapathi, S. S., Heald, B., Yang, Y.-R., Bebek, G., Romigh, T., Song, J. H., Wu, W., et al. (2011) · JAMA · doi:10.1001/jama.2011.1029 · Cited by 125
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
Jóhannsson, Ó. Þ., Loman, N., Møller, H., Kristoffersson, U., Borg, Å., & Olsson, H. L. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00135-5 · Cited by 122
Keller, G., Vogelsang, H., Becker, I., Plaschke, S., Ott, K., Suriano, G., Mateus, A. R., Seruca, R., Biedermann, K., Huntsman, D. D., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015594 · Cited by 111
Self-citationHebbard, P. C., MacMillan, A., Huntsman, D. G., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0471-z · Cited by 111
Self-citationHuman cationic trypsinogen (PRSS1) variants and chronic pancreatitis
Németh, B. C., & Sahin‐Tóth, M. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00419.2013 · Cited by 109
Cancer variation associated with the position of the mutation in the BRCA2 gene
Lubiński, J., Phelan, C. M., Ghadirian, P., Lynch, H. T., Garber, J. E., Weber, B., Tung, N., Horsman, D. E., Isaacs, C. J., Monteiro, Á. N. A., et al. (2004) · Familial Cancer · doi:10.1023/b:fame.0000026816.32400.45 · Cited by 102
Self-citationYabuta, T., Shinmura, K., Tani, M., Yamaguchi, S., Yoshimura, K., Katai, H., Nakajima, T., Mochiki, E., Tsujinaka, T., Takami, M., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10633 · Cited by 94
Germline CDH1 mutations in bilateral lobular carcinoma in situ
Petridis, C., Shinomiya, I., Kohut, K., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.792 · Cited by 79
A model to infer the pathogenic significance of CDH1 germline missense variants
Suriano, G., Seixas, S., Rocha, J., & Seruca, R. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0091-z · Cited by 69
Breast-Cancer Risk in Families with Mutations in PALB2
Thomas, P., & Brown, P. (2015) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2015.07.017 · Cited by 67
E-Cadherin Alterations in Hereditary Disorders with Emphasis on Hereditary Diffuse Gastric Cancer
Oliveíra, C., Pinheiro, H. C., Figueiredo, J., Seruca, R., & Carneiro, F. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394311-8.00015-7 · Cited by 63
Self-citationTheATMmissense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer
Stredrick, D. L., García‐Closas, M., Pineda, M. A., Bhatti, P., Alexander, B. H., Doody, M. M., Lissowska, J., Pepłońska, B., Brinton, L. A., Chanock, S. J., et al. (2006) · Human Mutation · doi:10.1002/humu.20323 · Cited by 59
Dussaulx-Garin, L., Blayau, M., Pagenault, M., et al. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200106000-00016 · Cited by 52
NovelCDH1germline mutations identified in Chinese gastric cancer patients
Chen, Q. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.909 · Cited by 22
Cited by
Current treatment and recent progress in gastric cancer
Joshi, S. S., & Badgwell, B. D. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21657 · Cited by 1,677
Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., & Sitarz, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114012 · Cited by 1,520
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
Thrift, A. P., Wenker, T. N., & El-Serag, H. B. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00747-0 · Cited by 828
Wang, F., Shen, L., Li, J., Zhou, Z., Liang, H., Zhang, X., Tang, L., Xin, Y., Jin, J., Zhang, Y., et al. (2019) · Cancer Communications · doi:10.1186/s40880-019-0349-9 · Cited by 810
Metadata
- Authors
- Hansford, S., Kaurah, P., Li-Chang, H., Woo, M., Senz, J., Pinheiro, H., Schrader, K. A., Schaeffer, D. F., Shumansky, K., Zogopoulos, G., Santos, T. A., Claro, I., Carvalho, J., Nielsen, C., Padilla, S., Lum, A., Talhouk, A., Baker-Lange, K., Richardson, S., Lewis, I., Lindor, N. M., Pennell, E., MacMillan, A., Fernandez, B., Keller, G., Lynch, H., Shah, S. P., Guilford, P., Gallinger, S., Corso, G., Roviello, F., Caldas, C., Oliveira, C., Pharoah, P. D. P., & Huntsman, D. G.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2015-04-01
- Volume
- 1
- Issue
- 1
- Pages
- 23
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2105956673
- Cited by
- 694
- References
- 57
- FWCI
- 39.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.